SG11201805533QA - Composition and methods for cryopreservation of hutc - Google Patents
Composition and methods for cryopreservation of hutcInfo
- Publication number
- SG11201805533QA SG11201805533QA SG11201805533QA SG11201805533QA SG11201805533QA SG 11201805533Q A SG11201805533Q A SG 11201805533QA SG 11201805533Q A SG11201805533Q A SG 11201805533QA SG 11201805533Q A SG11201805533Q A SG 11201805533QA SG 11201805533Q A SG11201805533Q A SG 11201805533QA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- johnson
- cryopreservation
- pct
- applicant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization 11M111110111011111111111 010 11111 01110111 0111 010 11111 1111 10111111111111 0111111 International Bureau ... .... ..Yjd (10) International Publication Number (43) International Publication Date ..... ...r .....1 WO 2017/123465 Al 20 July 2017 (20.07.2017) WIPO I PCT (51) International Patent Classification: AO1N 1/02 (2006.01) (21) International Application (22) International Filing Date: (25) Filing Language: (26) Publication Language: (30) Priority Data: 62/278,780 14 January (71) Applicant: DEPUY SYNTHES [US/US]; 325 Paramount 02767 (US). (72) Inventors: GOSIEWSKA, Skillman, New Jersey 08558 Welsh Road and McKean Pennsylvania 19477 (US). (74) Agents: SHIRTZ, Joseph DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, Number: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, PCT/US2017/012491 NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, 6 January 2017 (06.01.2017) TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. English (84) Designated States (unless otherwise indicated, for every English kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 2016 (14.01.2016) US TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, PRODUCTS, INC. DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, Drive, Raynham, Massachusetts LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, Anna; 199 Grandview Road GW, KM, ML, MR, NE, SN, TD, TG). , (US). KIHM, Anthony J.; Declarations under Rule 4.17: Road, Spring House, as to applicant's entitlement to apply for and be granted a patent (Rule 4. 17(ii)) F. et al.; Johnson & Johnson, as to the applicant's entitlement to claim the priority of the Plaza, New Brunswick, New Jer- earlier application (Rule 4. 17(iii)) Published: otherwise indicated, for every available): AE, AG, AL, AM, — with international search report (Art. 21(3)) BB, BG, BH, BN, BR, BW, BY, CR, CU, CZ, DE, DJ, DK, DM, One Johnson & Johnson sey 08933 (US). — (81) Designated States (unless kind of national protection AO, AT, AU, AZ, BA, BZ, CA, CH, CL, CN, CO, METHODS FOR CRYOPRESERVATION OF HUTC tissue-derived cells. The sucrose, mannitol, (54) Title: COMPOSITION AND 35 30 —30—FORMULATION B —.—FORMULATION I MOD, LOW Ca 25 20 ,,, — Figure 1 umbilical cord salts; and (d) DMSO, human umbilical cord tissue-derived cells LLI 0 151-- 11 10 kf) 1 1' Cr) N ,-1 N 1-1 (57) : This invention N cryopreservation compositions and lactobionic acid. The invention also provides for kits comprising the composition and 0 and methods of cryopreserving the cells, which utilize the compositions. ) C 0.5 1 15 2 2.5 3 3.5 4 45 TIME (hrs) provides for compositions for cryopreservation of human may comprise: (a) amino acids; (b) vitamins; (c) inorganic
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662278780P | 2016-01-14 | 2016-01-14 | |
| PCT/US2017/012491 WO2017123465A1 (en) | 2016-01-14 | 2017-01-06 | Composition and methods for cryopreservation of hutc |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805533QA true SG11201805533QA (en) | 2018-07-30 |
Family
ID=57838568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805533QA SG11201805533QA (en) | 2016-01-14 | 2017-01-06 | Composition and methods for cryopreservation of hutc |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10791730B2 (en) |
| EP (1) | EP3402329A1 (en) |
| JP (1) | JP6855489B2 (en) |
| KR (1) | KR102211270B1 (en) |
| CN (1) | CN108471736A (en) |
| AR (1) | AR107366A1 (en) |
| AU (1) | AU2017207707B2 (en) |
| BR (1) | BR112018014238A2 (en) |
| CA (1) | CA3010792A1 (en) |
| MX (1) | MX2018008712A (en) |
| PH (1) | PH12018501414A1 (en) |
| RU (1) | RU2748057C2 (en) |
| SG (1) | SG11201805533QA (en) |
| WO (1) | WO2017123465A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10791730B2 (en) | 2016-01-14 | 2020-10-06 | DePuy Synthes Products, Inc. | Composition and methods for cryopreservation of hUTC |
| US11485953B2 (en) | 2016-10-04 | 2022-11-01 | Transwell Biotech Co., Ltd. | Compositions and methods for maintaining cell viability |
| EP3531832A4 (en) | 2016-10-25 | 2020-08-05 | Marquette University | Storage media and powder formulations for avulsed teeth and explanted tissues comprising fibroblasts |
| CN108235981B (en) * | 2016-12-23 | 2021-07-23 | 西比曼生物科技（香港）有限公司 | Cell cryopreservation liquid capable of being used clinically |
| CN107683849A (en) * | 2017-10-12 | 2018-02-13 | 北京臻惠康生物科技有限公司 | A kind of mesenchymal stem cell cryopreserving liquid, preparation method and its application method of directly intravenous applications |
| RU2707921C1 (en) * | 2018-12-10 | 2019-12-02 | Федеральное государственное бюджетное учреждение науки "Кировский научно-исследовательский институт гематологии и переливания крови Федерального медико-биологического агентства" | Method for unrestricted freezing peripheral blood precursor cells at minus 80 °c under protection of dimethylsulphoxid |
| CA3129732A1 (en) * | 2019-02-14 | 2020-08-20 | North Grove Investments, Inc. | Compositions for maintaining the viability of living and static biological material, methods of making and the uses thereof |
| CN112741081B (en) * | 2021-01-29 | 2021-12-21 | 华夏源(上海)生物科技有限公司 | Programmed cooling method for human umbilical cord mesenchymal stem cells with excellent freezing and cooling effects |
| CN112913833B (en) * | 2021-01-29 | 2022-10-14 | 华夏源细胞工程集团股份有限公司 | Programmed cooling method for human umbilical cord mesenchymal stem cell working cell bank |
| CN112741082A (en) * | 2021-01-29 | 2021-05-04 | 华夏源细胞工程集团股份有限公司 | Method for detecting influence of cooling process on cryopreservation effect of human umbilical cord mesenchymal stem cells |
| CN112889813B (en) * | 2021-01-29 | 2022-10-18 | 华夏源细胞工程集团股份有限公司 | Cryopreservation method of human umbilical cord mesenchymal stem cells with high cell survival rate |
| CN114762500A (en) * | 2021-05-14 | 2022-07-19 | 达瑟儿(上海)生命科技有限公司 | Cell cryopreservation method with high survival rate |
| CN115299431B (en) * | 2022-07-21 | 2024-01-05 | 广东崖山生物科技有限公司 | Preservation solution for maintaining cell activity, preparation method thereof and method for preserving cells |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4205399A (en) | 1977-06-13 | 1980-06-03 | Ethicon, Inc. | Synthetic absorbable surgical devices of poly(alkylene oxalates) |
| US4938961A (en) * | 1989-04-28 | 1990-07-03 | Geoffrey Collins | Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia |
| ATE145235T1 (en) | 1990-01-22 | 1996-11-15 | Us Health | CO-INDEPENDENT NUTRITION MEDIUM FOR MAINTAINING AND PRODUCING CELLS |
| US6013067A (en) | 1995-06-07 | 2000-01-11 | Zymogenetics, Inc. | Methods for increasing hematopoietic cells |
| CN1626048B (en) | 1997-01-24 | 2012-09-12 | 帕拉贡知识产权有限责任公司 | Expandable device having bistable spring construction |
| CA2307807C (en) | 1997-10-23 | 2008-09-02 | Andrea G. Bodnar | Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture |
| US6485959B1 (en) * | 1998-10-07 | 2002-11-26 | Cedars Sinai Medical Center | Cell preconditioning and cryopresevation medium |
| US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| US7455983B2 (en) | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
| EP1360314B1 (en) | 2001-02-15 | 2009-01-14 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
| US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| AU2002226426A1 (en) | 2002-01-09 | 2003-07-24 | Alberto Gorrochategui Barrueta | Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements |
| RU2237712C2 (en) * | 2002-05-06 | 2004-10-10 | Кострикин Александр Александрович | Medium for cryopreserving human and animal cells |
| US7560276B2 (en) | 2003-06-27 | 2009-07-14 | Ethicon, Incorporated | Soft tissue repair and regeneration using postpartum-derived cells |
| EP1475434A1 (en) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Method for storing tumor cells |
| US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
| AU2005271723B2 (en) | 2004-07-13 | 2010-12-16 | Asterias Biotherapeutics, Inc. | Medium for growing human embryonic stem cells |
| CA2585547A1 (en) | 2004-10-29 | 2006-05-11 | Centocor, Inc. | Chemically defined media compositions |
| PE20110020A1 (en) * | 2005-10-13 | 2011-01-31 | Anthrogenesis Corp | IMMUNOMODULATION THROUGH THE USE OF PLACENTA STEM CELLS |
| US8968994B2 (en) | 2006-07-06 | 2015-03-03 | Jeremy Micah Crook | Method for stem cell culture and cells derived therefrom |
| CN101611139B (en) | 2006-11-13 | 2012-07-04 | 伊西康公司 | In vitro expansion of postpartum-derived cells using microcarriers |
| WO2008082525A1 (en) | 2006-12-19 | 2008-07-10 | National Stem Cell Inc | Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof |
| WO2009020389A1 (en) | 2007-08-03 | 2009-02-12 | Campina Nederland Holding B.V. | Culture medium for eukaryotic cells |
| ES2352046T3 (en) | 2007-09-21 | 2011-02-15 | Universität Leipzig | MEANS OF CELL CULTURE AND PROCEDURE OF CULTURE OF MOTHER CELLS AND PROGENITOR CELLS. |
| KR20100097726A (en) * | 2007-12-04 | 2010-09-03 | 프로테오바이오엑티브스 피티와이 엘티디 | Protection of progenitor cells and regulation of their differentiation |
| NO331476B1 (en) * | 2007-12-21 | 2012-01-16 | Jaffar Ali Bin M Abdullah | Protein-free gamete and embryo handling and culture media products containing methyl cellulose |
| WO2009092789A1 (en) | 2008-01-25 | 2009-07-30 | Cell Med Research Gmbh | Medium for propagating and expanding stem cells |
| DK2130906T3 (en) | 2008-06-04 | 2014-05-12 | Biosilta Oy | Process for applying growth components to cell cultures |
| JP5940975B2 (en) * | 2009-07-20 | 2016-06-29 | ザ ジェネラル ホスピタル コーポレーション ディー／ビー／エイ マサチューセッツ ジェネラル ホスピタル | Methods and compositions for improving the viability of cryopreserved cells |
| WO2011101834A1 (en) * | 2010-02-22 | 2011-08-25 | Advanced Neuro-Science Allies Private Limited | A method for obtaining mesenchymal stem cells, media, methods and composition thereof |
| CN103783031B (en) * | 2012-10-29 | 2015-11-18 | 四川新生命干细胞科技股份有限公司 | A kind of cell-preservation liquid |
| US20140170748A1 (en) | 2012-12-14 | 2014-06-19 | DePuy Synthes Products, LLC | Nutrient Enriched Media for hUTC Growth |
| CN103891709A (en) * | 2012-12-24 | 2014-07-02 | 深圳先进技术研究院 | Cell cryopreservation liquid and cell cryopreservation method |
| CN106659148A (en) * | 2014-05-12 | 2017-05-10 | 鲁斯特生物股份有限公司 | Ready-to-print cells and integrated devices |
| CN104771374A (en) * | 2015-04-20 | 2015-07-15 | 北京红太阳药业有限公司 | Preparation method of lactobionic acid azithromycin freeze-dried powder injection for injection and freeze-dried powder injection prepared by preparation method |
| CN105145545B (en) * | 2015-07-27 | 2017-11-03 | 北京泛生子基因科技有限公司 | Nuclease protection liquid for long-term storage and transport tissue samples under normal temperature condition |
| RU2599418C1 (en) * | 2015-10-06 | 2016-10-10 | Общество с ограниченной ответственностью "Научно-производственная компания Стемма" | Method for preparing cell material from human placenta |
| CN105145547B (en) * | 2015-10-28 | 2018-07-10 | 广州赛莱拉干细胞科技股份有限公司 | A kind of umbilical cord mesenchymal stem cells freeze protection liquid and cryopreservation methods |
| US10791730B2 (en) | 2016-01-14 | 2020-10-06 | DePuy Synthes Products, Inc. | Composition and methods for cryopreservation of hUTC |
-
2017
- 2017-01-06 US US15/400,022 patent/US10791730B2/en active Active
- 2017-01-06 CA CA3010792A patent/CA3010792A1/en not_active Abandoned
- 2017-01-06 KR KR1020187023353A patent/KR102211270B1/en active IP Right Grant
- 2017-01-06 EP EP17700764.8A patent/EP3402329A1/en not_active Withdrawn
- 2017-01-06 WO PCT/US2017/012491 patent/WO2017123465A1/en active Application Filing
- 2017-01-06 JP JP2018536808A patent/JP6855489B2/en active Active
- 2017-01-06 MX MX2018008712A patent/MX2018008712A/en unknown
- 2017-01-06 AU AU2017207707A patent/AU2017207707B2/en not_active Ceased
- 2017-01-06 CN CN201780006784.0A patent/CN108471736A/en active Pending
- 2017-01-06 BR BR112018014238A patent/BR112018014238A2/en not_active Application Discontinuation
- 2017-01-06 RU RU2018129431A patent/RU2748057C2/en active
- 2017-01-06 SG SG11201805533QA patent/SG11201805533QA/en unknown
- 2017-01-13 AR ARP170100102A patent/AR107366A1/en unknown
-
2018
- 2018-07-02 PH PH12018501414A patent/PH12018501414A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10791730B2 (en) | 2020-10-06 |
| US20170202212A1 (en) | 2017-07-20 |
| KR102211270B1 (en) | 2021-02-04 |
| EP3402329A1 (en) | 2018-11-21 |
| PH12018501414A1 (en) | 2019-01-28 |
| AR107366A1 (en) | 2018-04-25 |
| BR112018014238A2 (en) | 2018-12-11 |
| RU2018129431A3 (en) | 2020-10-14 |
| AU2017207707B2 (en) | 2020-12-17 |
| WO2017123465A1 (en) | 2017-07-20 |
| KR20180100681A (en) | 2018-09-11 |
| JP2019503181A (en) | 2019-02-07 |
| CN108471736A (en) | 2018-08-31 |
| MX2018008712A (en) | 2019-06-06 |
| JP6855489B2 (en) | 2021-04-07 |
| CA3010792A1 (en) | 2017-07-20 |
| AU2017207707A1 (en) | 2018-07-12 |
| RU2748057C2 (en) | 2021-05-19 |
| RU2018129431A (en) | 2020-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201805533QA (en) | Composition and methods for cryopreservation of hutc | |
| SG11201908670SA (en) | Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators | |
| SG11201804152RA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201803920TA (en) | Compounds and compositions useful for treating disorders related to ntrk | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201908560SA (en) | Heterocyclic compounds useful as dual atx/ca inhibitors | |
| SG11201805940QA (en) | Benzopyrazole compounds and analogues thereof | |
| SG11201810579YA (en) | Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201804936UA (en) | Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| SG11201805387RA (en) | Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists | |
| SG11201907356SA (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201900238UA (en) | Compounds and methods for modulation of smn2 | |
| SG11201908691PA (en) | Compounds and methods for the treatment of parasitic diseases | |
| SG11201811686UA (en) | 18f-labeled triazole containing psma inhibitors | |
| SG11201804587QA (en) | Isoindole compounds | |
| SG11201805423TA (en) | Indolinones compounds and their use in the treatment of fibrotic diseases | |
| SG11201407575PA (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
| SG11201806623VA (en) | Bacteria over-expressing c-di-amp and therapeutic methods | |
| SG11201907505TA (en) | Low-viscosity, high-concentration evolocumab formulations and methods of making the same |